WallStSmart

AMN Healthcare Services Inc (AMN)vsFresenius Medical Care Corporation (FMS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Fresenius Medical Care Corporation generates 466% more annual revenue ($19.36B vs $3.42B). FMS leads profitability with a 4.9% profit margin vs -0.9%. FMS appears more attractively valued with a PEG of 0.79. AMN earns a higher WallStSmart Score of 62/100 (C+).

AMN

Buy

62

out of 100

Grade: C+

Growth: 7.3Profit: 4.0Value: 6.3Quality: 5.5
Piotroski: 4/9Altman Z: 2.27

FMS

Buy

50

out of 100

Grade: C-

Growth: 2.7Profit: 5.0Value: 9.3Quality: 6.0
Piotroski: 6/9Altman Z: 1.96
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AMNUndervalued (+60.2%)

Margin of Safety

+60.2%

Fair Value

$49.13

Current Price

$31.69

$17.44 discount

UndervaluedFair: $49.13Overvalued
FMSUndervalued (+69.0%)

Margin of Safety

+69.0%

Fair Value

$77.65

Current Price

$22.03

$55.62 discount

UndervaluedFair: $77.65Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AMN3 strengths · Avg: 9.3/10
Revenue GrowthGrowth
99.9%10/10

Revenue surging 99.9% year-over-year

EPS GrowthGrowth
321.3%10/10

Earnings expanding 321.3% YoY

Price/BookValuation
1.7x8/10

Reasonable price relative to book value

FMS3 strengths · Avg: 9.3/10
P/E RatioValuation
11.9x10/10

Attractively priced relative to earnings

Price/BookValuation
0.8x10/10

Reasonable price relative to book value

PEG RatioValuation
0.798/10

Growing faster than its price suggests

Areas to Watch

AMN4 concerns · Avg: 3.0/10
PEG RatioValuation
1.714/10

Expensive relative to growth rate

Market CapQuality
$1.17B3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.093/10

Elevated debt levels

Return on EquityProfitability
-4.5%2/10

ROE of -4.5% — below average capital efficiency

FMS4 concerns · Avg: 3.0/10
Altman Z-ScoreHealth
1.964/10

Grey zone — moderate risk

Return on EquityProfitability
7.1%3/10

ROE of 7.1% — below average capital efficiency

Profit MarginProfitability
4.9%3/10

4.9% margin — thin

Revenue GrowthGrowth
-5.5%2/10

Revenue declined 5.5%

Comparative Analysis Report

WallStSmart Research

Bull Case : AMN

The strongest argument for AMN centers on Revenue Growth, EPS Growth, Price/Book. Revenue growth of 99.9% demonstrates continued momentum.

Bull Case : FMS

The strongest argument for FMS centers on P/E Ratio, Price/Book, PEG Ratio. PEG of 0.79 suggests the stock is reasonably priced for its growth.

Bear Case : AMN

The primary concerns for AMN are PEG Ratio, Market Cap, Debt/Equity.

Bear Case : FMS

The primary concerns for FMS are Altman Z-Score, Return on Equity, Profit Margin. Thin 4.9% margins leave little buffer for downturns.

Key Dynamics to Monitor

AMN profiles as a hypergrowth stock while FMS is a value play — different risk/reward profiles.

FMS carries more volatility with a beta of 0.81 — expect wider price swings.

AMN is growing revenue faster at 99.9% — sustainability is the question.

AMN generates stronger free cash flow (555M), providing more financial flexibility.

Bottom Line

AMN scores higher overall (62/100 vs 50/100) and 99.9% revenue growth. FMS offers better value entry with a 69.0% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

AMN Healthcare Services Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

AMN Healthcare Services, Inc. provides healthcare personnel solutions and staffing services to hospitals and healthcare facilities in the United States. The company is headquartered in Dallas, Taxas.

Visit Website →

Fresenius Medical Care Corporation

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America and internationally. The company is headquartered in Bad Homburg, Germany.

Visit Website →

Want to dig deeper into these stocks?